Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) – Stock analysts at SVB Leerink decreased their Q3 2023 earnings estimates for shares of Roivant Sciences in a research report issued to clients and investors on Sunday, December 18th. SVB Leerink analyst D. Risinger now forecasts that the company will earn ($0.32) per share for the quarter, […]
